Vermox 500 mg tablets

Each tablet contains 500 mg mebendazole polymorph C

VERMOX^® 500 mg is indicated for the treatment of single and mixed helminth gastrointestinal infestations caused by: 

Nematodes such as: 

• Trichuris trichiura (whipworm) 

• Ancylostoma duodenale (hookworm) 

• Necator americanus (hookworm) 

• Ascaris lumbricoides (large roundworm) 

• Enterobius vermicularis (pinworm) 

Whipworm; Hookworm; Large Roundworm; Pinworm:

Adults and children older than 1 year:
One tablet (500 mg) given as a single dose. The tablets may be crushed and given with some liquid for children. 

A single dose of VERMOX^® 500 mg may not be sufficient to cure infestations with hookworm and whipworm (Trichuris) although a substantial reduction in egg count can be expected. 

A second course of treatment should be given to those patients who are still infected three to four weeks after the first course. 

In worm-eradication campaigns the standard course should be administered every quarter during the first year.

1. Honoratu SB, Farfan S, Viana A, et al. Polymorphism Evaluation in Generic Tablets containing Mebendazole by Dissolution Tests. J. Braz. Chem. Soc. 2012;23(2):220-227.

2. Swanepoel E, Liebenberg W, Melgardt M de Villiers. Quality evaluation of generic drugs by dissolution test: changing the USP dissolution medium to distinguish between active and non-active mebendazole polymorphs. European Journal of Pharmaceutics and Biopharmaceutics, 2003;55:345-349.

S1 VERMOX^® 500 mg tablets. Each tablet contains 500 mg MEBENDAZOLE POLYMORPH C. Reg. No. W/12/42.  

For full prescribing information, refer to the Professional Information approved by the medicines regulatory authority. 

ZA-VE-2400009